TCM
GOSS icon

Traynor Capital Management’s Gossamer Bio GOSS Stock Holding History

Traynor Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,272
Closed -$25.6K – 278
2025
Q1 		$25.6K Buy
23,272
+9,272
+66% +$10.7K ﹤0.01% 243
2024
Q4 		$12.7K Hold
14,000
– – ﹤0.01% 284
2024
Q3 		$13.8K Buy
14,000
+4,000
+40% +$3.85K ﹤0.01% 273
2024
Q2 		$9.01K Buy
+10,000
New +$7.48K ﹤0.01% 279

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Traynor Capital Management's GOSS Position: Q2 2025 in Review

Traynor Capital Management sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 23,272 shares — an estimated $25.6K sold.

Traynor Capital Management first reported a position in GOSS in Q2 2024 and held it in 4 quarters. The position peaked at $25.6K in Q1 2025. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • Traynor Capital Management reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • Traynor Capital Management sold 23,272 Gossamer Bio shares in Q2 2025, an estimated $25.6K.
  • Traynor Capital Management first reported a position in Gossamer Bio in Q2 2024 and held it in 4 quarters.
  • Traynor Capital Management's Gossamer Bio position peaked at $25.6K in Q1 2025.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Traynor Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.